Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Vertex Pharmaceuticals Inc. buy geldnutzer

Start price
€177.98
22.10.20 / 50%
Target price
€190.00
2021-11-04
Performance (%)
2.71%
Price
€182.80
09:23
This prediction is currently active. With a performance of 2.71%, the BUY prediction by geldnutzer for Vertex Pharmaceuticals Inc. is trending in the right direction. This prediction currently runs until 2021-11-04. The prediction end date can be changed by geldnutzer at any time. geldnutzer has 50% into this prediction

According to geldnutzer what are the pros and cons of Vertex Pharmaceuticals Inc. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Rising EBIT margin expected
positive Cash Flow expected
Good rating
High Investments for future growth
Very valuable balance sheet
ROE higher than 15% per year
Small challenges to pay loans and raise capital
Good culture
Capable Management
Strong uniques
Very differentiated customer and product portfolio
Sustainability is important
Stable Large shareholder and/or long term investor
Medium risks for its business
Small cyclical dependencies
Undervalued
Leading role in innovation
Growths much faster than the competition
Well known brand
Very Future proof/growth oriented business model
Cons

Comments by geldnutzer for this prediction

In the thread Vertex Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) 2.71%
Target price 210.000
Change
Ends at 04.11.21

Buy mit Kursziel 210,0

Prediction Buy
Perf. (%) 2.71%
Target price 200.000
Change
Ends at 04.11.21

Kursziel geändert auf 200,0

Prediction Buy
Perf. (%) 2.71%
Target price 210.000
Change
Ends at 04.11.21

Kursziel geändert auf 210,0

Prediction Buy
Perf. (%) 2.71%
Target price 180.000
Change
Ends at 04.11.21

Kursziel geändert auf 180,0

Prediction Buy
Perf. (%) 2.71%
Target price 190.000
Change
Ends at 04.11.21

Kursziel geändert auf 190,0